ALK expression in extranodal anaplastic large cell lymphoma layouts systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination

Journal of Clinical Pathology

Volumn 53, Issue 6, 2000, Pages 445-450

  Ten Berge, Rosita L ^a   Oudejans, Joost J ^a   Ossenkoppele, Gert Jan ^a   Pulford, Karen ^b   Willemze, Rein ^a   Falini, Brunangelo ^c   Chott, Andreas ^d   Meijer, Chris J L M ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^c UNIVERSITY OF PERUGIA   (Italy)

^d UNIVERSITY OF VIENNA   (Austria)

Author keywords

Anaplastic large cell lymphoma; Anaplastic lymphoma kinase; Extranodal; Survival

Indexed keywords

ANAPLASTIC LYMPHOMA KINASE; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG;

ANAPLASTIC CARCINOMA; ARTICLE; CANCER SURVIVAL; DISEASE ASSOCIATION; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SURVIVAL TIME; TISSUE DISTRIBUTION;

ADOLESCENT; ADULT; AGED; CHILD; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; LYMPH NODES; LYMPHOMA, LARGE-CELL, KI-1; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NOSE NEOPLASMS; PROGNOSIS; PROTEIN-TYROSINE KINASES; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0034045628     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.53.6.445     Document Type: Article

References (35)

1. 1 Stein H, Mason DY, Gerdes J, et al. The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 1985;66:848-58.
2. 2 Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms; a proposal from the international lymphoma study group. Blood 1994; 84:1361-92.
3. 3 de Bruin PC, Beljaards RC, van Heerde P, et al. Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype. Histopathology 1993;23:127-35.
4. 4 de Bruin PC, Noorduyn AL, van der Valk P, et al. Noncutaneous T-cell lymphomas. Recognition of a lymphoma type (large cell anaplastic) with a relatively favourable prognosis. Cancer 1993;71:2604-612.
5. 5 Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer. Blood 1997;90:354-71.
6. 6 Tilly H, Gaulard P, Lepage E, et al. Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome. Blood 1997;90:3727-34.
7. 7 Jaffe ES, Chan JKC, Su IJ, et al. Report of the workshop on nasal and related extranodal angiocentric T/natural killer cell lymphomas. Am J Surg Pathol 1996;20:103-11.
8. 8 Sanchezbueno F, Garciamarcilla JA, Alonso JD, et al. Prognostic factors in primary gastrointestinal non-Hodgkins lymphomas a multivariate analysis of 76 cases. Eur J Surg 1998;164:385-92.
9. 9 Zinzani PL, Magagnoli M, Pagliani G, et al. Primary intestinal lymphoma - clinical and therapeutic features of 32 patients. Haematologica 1997;82:305-8.
10. 10 Morris SW, Kirstein MN, Valentine MB, et al. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 1994;263:1281-4.
11. 11 Lamant L, Dastugue N, Pulford K, et al. A new fusion gene TPM3 ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation. Blood 1999;93:3088-95.
12. 12 Wlodarska I, De Wolf-Peeters C, Falini B, et al. The cryptic inv(2)(p23q35) defines a new molecular genetic subtype of ALK-positive anaplastic large cell lymphoma. Blood 1998;92:2688-695.
13. 13 Mason DY, Pulford KAP, Bischof D, et al. Nucleolar localization of the nucleophosmin-anaplastic lymphoma kinase is not required for malignant transformation. Cancer Res 1998;58:1057-62.
14. 14 Bischof D, Pulford K, Mason DY, et al. Role of nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic kinase fusion protein in oncogenesis. Mol Cell Biol 1997;17:2312-25.
15. 15 Pulford K, Lamant L, Morris SW, et al. Detection of anaplastic lymphoma kinase (ALK) and nucleolar protein nucleophosmin (NPM) ALK proteins in normal and neoplastic cells with the monoclonal antibody ALK1. Blood 1997;89:1394-404.
16. 16 Lamant L, Meggetto F, Al Saati T, et al. High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease: comparison of cytogenetic analysis, reverse transcriptase polymcrasc chain reaction, and p80 immunostaining. Blood 1996;87:284-91.
17. 17 Falini B, Bigerna B, Fizzotti M, et al. ALK expression defines a distinct group of T/null lymphomas ("ALK lymphomas") with a wide morphological spectrum. Am J Pathol 1998;153:875-86.
18. 18 Shiota M, Takenaga M, Satoh H, et al. Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood 1994;84:3648-52.
19. 19 ten Berge RL, Dukers DF, Oudejans JJ, et al. Adverse effects of activated cytotoxic T-lymphocytes on the clinical outcome of nodal anaplastic large cell lymphoma. Blood 1999;93:2688-96.
20. 20 Sandlund JT, Pui CH, Roberts M, et al. Clinicopathologic features and treatment outcome of children with large-cell lymphoma and the t(2;5)(p23;q35). Blood 1994;84:2467-71.
21. 21 Shiota M, Nakamura S, Ichinoshama R, et al. Anaplastic large cell lymphomas expressing the novel chimeric protein p80 NPM/ALK: a distinct clinicopathologic entity. Blood 1995;86:1954-60.
22. 22 Falini B, Pileri S, Zinzani PL, et al. ALK-positive lymphoma: clinicopathological findings and outcome. Blood 1999;93:2697-706.
23. 23 Gascoyne RD, Aoun P, Wu D, et al. Prognostic significance of anaplastic lymphoma kinase (ALK) protein expression in adults with anaplastic large cell lymphoma. Blood 1999; 93:3913-21.
24. 24 Herbst H, Sander C, Tronnier M, et al. Absence of anaplastic lymphoma kinase (ALK) and Epstein-Barr virus gene products in primary cutaneous anaplastic large cell lymphoma and lymphomatoid papulosis. Br J Dermatol 1997;137:680-6.
25. 25 DeCoteau JF, Butmarc JR, Kinney MC, et al. The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lympoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin. Blood 1996;87:3437-41.
26. 26 Pittaluga S, Wlodarska I, Pulford K, et al. The monoclonal antibody ALK1 identifies a distinct morphological subtype of anaplastic large cell lymphoma associated with 2p23/ALK rearrangements. Am J Pathol 1997;151:343-51.
27. 27 Ott G, Katzenberger T, Siebert R, et al. Chromosomal abnormalities in nodal and extranodal CD30+ anaplastic large cell lymphomas - infrequent detection of the t(2;5) in extranodal lymphomas. Genes Chromosomes Cancer 1998; 22:114-21.
28. 28 Beylot-Barry M, Lamant L, Vergier B, et al. Detection of t(2;5)(p23:q35) translocation by reverse transcriptase polymerase chain reaction and in situ hybridization in CD30-positive primary cutaneous lymphoma and lymphomatoid papulosis. Am J Pathol 1996;149:483-92.
29. 29 Su LD, Schnitzer B, Ross CW, et al. The t(2;5)-associated p80 NPM/ALK fusion protein in nodal and cutaneous CD30+ lymphoproliferative disorders. J Cutan Pathol 1997;24:597-603.
30. 30 Benharroch D, Meguerian-Bedoyan Z, Lamant L, et al. ALK-positive lymphoma: a single disease with a broad spectrum of morphology. Blood 1998;91:2076-84.
31. 31 Kinney MC, Collins RD, Greer JP, et al. A small cell predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma. Am J Surg Pathol 1993;17:859-68.
32. 32 Bobrow MN, Shaughnessy KJ, Litt GJ. Catalysed reporter deposition: a novel method of signal amplification. H. Application to membrane immunoassays. J Immunol Methods 1991;137:103-12.
33. 33 Fujimoto J, Shiota M, Iwahara T, et al. Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5). Proc Natl Acad Sci U S A 1996;93:4181-6.
34. 34 Wellmann A, Doseeva V, Butscher W, et al. The activated anaplastic lymphoma kinase increases cellular proliferation and oncogene up-regulation in rat 1A fibroblasts. FASEB J 1997;11:965-72.
35. 35 Kuefer MU, Look AT, Pulford K, et al. Retrovirus-mediated transfer of NPM ALK causes lymphoid malignancy in mice. Blood 1997;90:2901-10.